MRKNYSEPharmaceutical PreparationsFiscal year ends December 31
Merck & Co., Inc.
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 7, 2026
$143.63−2.32 (-1.59%)
Close on Oct 19, 2026
- Market cap
- $354.77B
- P/E (TTM)
- 114.9
- Dividend yield
- 2.28%
Dividends
Dividend declared per share by fiscal year, adjusted for stock splits
Per share, FY2025
$3.28
+5.1% on the prior year
Consecutive increases
15 years
Every year since FY2010
Dividend yield
2.28%
Latest annual dividend ÷ share price
Payout ratio, FY2025
44.8%
Dividends paid ÷ net income
Dividend history
By fiscal year
| Fiscal year | Per share | Change | Cash paid | Payout ratio |
|---|---|---|---|---|
| FY2025 | $3.28 | +5.1% | $8.18B | 44.8% |
| FY2024 | $3.12 | +5.4% | $7.84B | 45.8% |
| FY2023 | $2.96 | +5.7% | $7.45B | 2039.7% |
| FY2022 | $2.80 | +6.1% | $7.01B | 48.3% |
| FY2021 | $2.64 | +6.5% | $6.61B | 50.7% |
| FY2020 | $2.48 | +9.7% | $6.22B | 87.9% |
| FY2019 | $2.26 | +13.6% | $5.70B | 57.9% |
| FY2018 | $1.99 | +5.3% | $5.17B | 83.2% |
| FY2017 | $1.89 | +2.2% | $5.17B | 215.8% |
| FY2016 | $1.85 | +2.2% | $5.12B | 130.7% |
| FY2015 | $1.81 | +2.3% | $5.12B | 115.2% |
| FY2014 | $1.77 | +2.3% | $5.17B | 43.4% |
| FY2013 | $1.73 | +2.4% | $5.16B | 117.1% |
| FY2012 | $1.69 | +8.3% | $5.12B | 82.9% |
| FY2011 | $1.56 | +2.6% | $4.69B | 74.8% |
Ex-dividend and payment dates for each distribution will appear once a dividend calendar source is connected.